PM
Get informed when a big investor buys or sells
+ FollowApril 22, 2026 - AI Summary
Undervalued by 35.9% based on the discounted cash flow analysis.
| Market cap | $276.46 Billion |
|---|---|
| Enterprise Value | $322.96 Billion |
| Dividend Yield | $5.76 (3.25%) |
| Earnings per Share | $7.27 |
| Beta | 0.39 |
| Outstanding Shares | 1,562,820,513 |
| P/E Ratio | 24.98 |
|---|---|
| PEG | -266.69 |
| Price to Sales | 6.77 |
| Price to Book Ratio | -35.19 |
| Enterprise Value to Revenue | 7.78 |
| Enterprise Value to EBIT | 20.17 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | -5.6 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.9970▼ 19.30% |
|---|---|
| Total Calls | 5,598,094▲ 2.09% |
| Total Puts | 5,581,562▼ 14.47% |
Holdings and activity of institutional investors.
| Ownership % | 83.24%▲ 0.77% |
|---|---|
| Total Invested | $214.05B▲ 3.94% |
| Investors Holding | 2,907▲ 34.00% |
No data
Provides crucial analysis and scoring for tax legislation, directly shaping corporate tax policy and the overall tax burden on a company like PM.
Has direct control over corporate taxation, which significantly impacts PM's profitability, and trade policy, which is critical for its global operations and supply chains.
Directly oversees the FDA, which is a primary regulator for tobacco products, impacting product development, marketing, and sales, making it critically important for PM.
Has jurisdiction over antitrust laws, which can affect market concentration and mergers in the tobacco industry, and intellectual property protection, vital for PM's brands and product innovations.
PM operates globally; committee actions on sanctions, trade agreements, and foreign policy can directly impact its international markets, supply chains, and profitability.